MAKO Surgical Corp (MAKO) Tops Q3 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/7/2026
- S&P 500, Nasdaq reach record closing highs as focus pivots to earnings
- Oil prices fall nearly 2% as Middle East supply concerns ease
- U.S. 10-year yield climb revives dotcom-era parallels: UBS weighs in
- Goldman flags 2 key market risks if a climb in yields persists
- Shell CEO says Middle East oil flows reach 80% of prewar levels
- HubSpot to cut 7% of workforce in restructuring plan
- Emera and Canadian Utilities agree to merge in $72B all-share deal
- Caribou Biosciences to halt CAR-T programs, explore sale
- Stryker names Spencer Stiles as CEO, Lobo moves to chair
- Francis Halzen wins Nobel physics prize for Antarctic 'ghost particle' hunt
With MAKO Surgical (MAKO) Q3 Mixed Canaccord Genuity Maintains Hold
November 8, 2012 2:02 PM ESTCanaccord Genuity maintained a Hold rating on MAKO Surgical (NASDAQ: MAKO) and raised its price target to $17.00 (from $14.00).
"Last quarter, we stated that we would wait for these changes to bear fruit before getting aggressive on the name, and we continue with... More



